BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bruggeman LA, Sedor JR, O'Toole JF. Apolipoprotein L1 and mechanisms of kidney disease susceptibility. Curr Opin Nephrol Hypertens 2021;30:317-23. [PMID: 33767059 DOI: 10.1097/MNH.0000000000000704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Holliday MW Jr, Navaneethan SD. Editorial: Advancements in the management of kidney disease and electrolyte derangements. Curr Opin Nephrol Hypertens 2022;31:395-8. [PMID: 35894272 DOI: 10.1097/MNH.0000000000000823] [Reference Citation Analysis]
2 Friedman DJ, Ma L, Freedman BI. Treatment potential in APOL1-associated nephropathy. Current Opinion in Nephrology & Hypertension 2022;31:442-8. [DOI: 10.1097/mnh.0000000000000816] [Reference Citation Analysis]
3 Gadegbeku CA, Sedor JR. APOL1 Kidney Risk Variants and Acute Kidney Injury in Those with COVID-19: True Association or Red Herring? CJASN 2021;16:1779-80. [DOI: 10.2215/cjn.13571021] [Reference Citation Analysis]